CSIMarket


Mersana Therapeutics inc   (NASDAQ: MRSN)
Other Ticker:  
 

Mersana Therapeutics inc

MRSN's Fundamental analysis








Looking into Mersana Therapeutics Inc growth rates, revenue grew by 63.65 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1295

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.75 %

Mersana Therapeutics Inc net loss decreased from $-42 millions, to $-12 millions in III. Quarter 2024,

More on MRSN's Growth


Mersana Therapeutics Inc
realized a net loss in trailing twelve months.

Mersana Therapeutics Inc realized cash reduction of $ -0.88 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
614.77
PE TTM    
Company's Price to Sales ratio is at 2.18.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.


More on MRSN's Valuation
 
 Total Debt (Millions $) 25
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 504,884
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 54.22
 Tangible Book Value (Per Share $) 0.01

Mersana Therapeutics Inc
realized net loss in trailing twelve months.

Mersana Therapeutics Inc realized cash outflow of $ -0.88per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
614.77
PE TTM    
Company's Price to Sales ratio is at 2.18.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.88.

Mersana Therapeutics Inc Price to Book Ratio is at 72.37 lower than Industry Avg. of 828.62. and higher than S&P 500 Avg. of 0.01

More on MRSN's Valuation

  Market Capitalization (Millions $) 76
  Shares Outstanding (Millions) 123
  Employees 69
  Revenues (TTM) (Millions $) 35
  Net Income (TTM) (Millions $) -75
  Cash Flow (TTM) (Millions $) -107
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) 25
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 504,884
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 54.22
  Tangible Book Value (Per Share $) 0.01

  Market Capitalization (Millions $) 76
  Shares Outstanding (Millions) 123
  Employees 69
  Revenues (TTM) (Millions $) 35
  Net Income (TTM) (Millions $) -75
  Cash Flow (TTM) (Millions $) -107
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 2.35
  Total Debt to Equity (MRQ) 24.27
  Tangible Leverage Ratio (MRQ) 160.61
  Asset Turnover Ratio (TTM) 0.19
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com